DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Walter E, Odin P.
Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s disease in the UK and Germany.
J Med Econ 2015;
18: 155-165
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.